BLADDER SMALL CELL NEUROENDOCRINE CARCINOMA
Clinical trials for BLADDER SMALL CELL NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BLADDER SMALL CELL NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for BLADDER SMALL CELL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for aggressive bladder and prostate cancers
Disease control OngoingThis early-stage trial is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy works better for treating advanced small cell or neuroendocrine cancers of the bladder, urethra, or prostate. The study will enroll about 15 participants with cancer tha…
Matched conditions: BLADDER SMALL CELL NEUROENDOCRINE CARCINOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test Triple-Threat drug combo against Tough-to-Treat cancers
Disease control OngoingThis early-stage study is testing the safety and best doses of a combination of cancer drugs for people with advanced cancers of the urinary system (like bladder and kidney cancer) that have spread. The trial combines a pill (cabozantinib) that aims to block tumor growth with one…
Matched conditions: BLADDER SMALL CELL NEUROENDOCRINE CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC